41 – 50 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation.
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
(2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842
- Contribution to journal › Article
-
Mark
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
- Contribution to journal › Published meeting abstract
-
Mark
Combining optical Cherenkov luminescence imaging and SPECT for intratherapy dosimetry in preclinical radionuclide therapy
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
MIRD Pamphlet No. 24: Guidelines for Quantitative I-131 SPECT in Dosimetry Applications
- Contribution to journal › Article
-
Mark
The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.
- Contribution to journal › Article
-
Mark
Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice : an 18F-FDG PET study
- Contribution to journal › Article
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes.
- Contribution to journal › Article
-
Mark
A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients
- Contribution to journal › Article
